APO RESEARCH · REPORT
Avian Influenza Vaccines
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.
Product & engineering
Understand the product.
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.
Selected research
Industry Research
Avian Influenza Vaccines Industry Research Report 2026
Market perspective
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.
Global Avian Influenza Vaccines key players include Merial, QYH Biotech, DHN, HVRI, etc. Global top four manufacturers hold a share over 80%.
China is the largest market, with a share about 45%, followed by Asia (Ex.China), and North America, both have a share about 40 percent.
Read the full market overview
In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.
Report Scope
This report quantifies the global Avian Influenza Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (M Doses), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Doses) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Avian Influenza Vaccines Market by Company
Merial
QYH Biotech
DHN
HVRI
CEVA
Elanco (Lohmann )
Yebio
Zoetis
FATRO
Kyoto Biken
CAVAC
Ringpu Biology
Vaksindo
ChengDu Tecbond
Sindh Poultry Vaccine Centre
Merck Animal Health
Medion
Avimex Animal Health
JOVAC
Bio-Labs
Avian Influenza Vaccines Segment by Type
H5+H7 Avian Influenza Vaccines
H9 Avian Influenza Vaccines
Avian Influenza Vaccines Segment by Application
Chicken Avian Influenza Vaccines
Duck & Goose Avian Influenza Vaccines
Other
Avian Influenza Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Avian Influenza Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Avian Influenza Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Avian Influenza Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Avian Influenza Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Avian Influenza Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Avian Influenza Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- H5+H7 Avian Influenza Vaccines
- H9 Avian Influenza Vaccines
Applications
- Chicken Avian Influenza Vaccines
- Duck & Goose Avian Influenza Vaccines
- Other
Companies covered
- Merial
- QYH Biotech
- DHN
- HVRI
- CEVA
- Elanco (Lohmann )
- Yebio
- Zoetis
- FATRO
- Kyoto Biken
- CAVAC
- Ringpu Biology
- Vaksindo
- ChengDu Tecbond
- Sindh Poultry Vaccine Centre
- Merck Animal Health
- Medion
- Avimex Animal Health
- JOVAC
- Bio-Labs
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Avian Influenza Vaccines Market Size (2021-2032)
- 2.2.2 Global Avian Influenza Vaccines Sales (2021-2032)
- 2.2.3 Global Avian Influenza Vaccines Market Average Price (2021-2032)
- 2.3 Avian Influenza Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 H5+H7 Avian Influenza Vaccines
- 2.3.3 H9 Avian Influenza Vaccines
- 2.4 Avian Influenza Vaccines by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Chicken Avian Influenza Vaccines
- 2.4.3 Duck & Goose Avian Influenza Vaccines
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Avian Influenza Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Avian Influenza Vaccines Sales (M Doses) of Manufacturers (2021-2026)
- 3.3 Global Avian Influenza Vaccines Revenue of Manufacturers (2021-2026)
- 3.4 Global Avian Influenza Vaccines Average Price by Manufacturers (2021-2026)
- 3.5 Global Avian Influenza Vaccines Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Avian Influenza Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Avian Influenza Vaccines, Product Type & Application
- 3.8 Global Manufacturers of Avian Influenza Vaccines, Established Date
- 3.9 Global Avian Influenza Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Merial
- 4.1.1 Merial Company Information
- 4.1.2 Merial Business Overview
- 4.1.3 Merial Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Merial Avian Influenza Vaccines Product Portfolio
- 4.1.5 Merial Recent Developments
- 4.2 QYH Biotech
- 4.2.1 QYH Biotech Company Information
- 4.2.2 QYH Biotech Business Overview
- 4.2.3 QYH Biotech Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 QYH Biotech Avian Influenza Vaccines Product Portfolio
- 4.2.5 QYH Biotech Recent Developments
- 4.3 DHN
- 4.3.1 DHN Company Information
- 4.3.2 DHN Business Overview
- 4.3.3 DHN Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 DHN Avian Influenza Vaccines Product Portfolio
- 4.3.5 DHN Recent Developments
- 4.4 HVRI
- 4.4.1 HVRI Company Information
- 4.4.2 HVRI Business Overview
- 4.4.3 HVRI Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 HVRI Avian Influenza Vaccines Product Portfolio
- 4.4.5 HVRI Recent Developments
- 4.5 CEVA
- 4.5.1 CEVA Company Information
- 4.5.2 CEVA Business Overview
- 4.5.3 CEVA Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 CEVA Avian Influenza Vaccines Product Portfolio
- 4.5.5 CEVA Recent Developments
- 4.6 Elanco (Lohmann )
- 4.6.1 Elanco (Lohmann ) Company Information
- 4.6.2 Elanco (Lohmann ) Business Overview
- 4.6.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Elanco (Lohmann ) Avian Influenza Vaccines Product Portfolio
- 4.6.5 Elanco (Lohmann ) Recent Developments
- 4.7 Yebio
- 4.7.1 Yebio Company Information
- 4.7.2 Yebio Business Overview
- 4.7.3 Yebio Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Yebio Avian Influenza Vaccines Product Portfolio
- 4.7.5 Yebio Recent Developments
- 4.8 Zoetis
- 4.8.1 Zoetis Company Information
- 4.8.2 Zoetis Business Overview
- 4.8.3 Zoetis Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Zoetis Avian Influenza Vaccines Product Portfolio
- 4.8.5 Zoetis Recent Developments
- 4.9 FATRO
- 4.9.1 FATRO Company Information
- 4.9.2 FATRO Business Overview
- 4.9.3 FATRO Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 FATRO Avian Influenza Vaccines Product Portfolio
- 4.9.5 FATRO Recent Developments
- 4.10 Kyoto Biken
- 4.10.1 Kyoto Biken Company Information
- 4.10.2 Kyoto Biken Business Overview
- 4.10.3 Kyoto Biken Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Kyoto Biken Avian Influenza Vaccines Product Portfolio
- 4.10.5 Kyoto Biken Recent Developments
- 4.11 CAVAC
- 4.11.1 CAVAC Company Information
- 4.11.2 CAVAC Business Overview
- 4.11.3 CAVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 CAVAC Avian Influenza Vaccines Product Portfolio
- 4.11.5 CAVAC Recent Developments
- 4.12 Ringpu Biology
- 4.12.1 Ringpu Biology Company Information
- 4.12.2 Ringpu Biology Business Overview
- 4.12.3 Ringpu Biology Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Ringpu Biology Avian Influenza Vaccines Product Portfolio
- 4.12.5 Ringpu Biology Recent Developments
- 4.13 Vaksindo
- 4.13.1 Vaksindo Company Information
- 4.13.2 Vaksindo Business Overview
- 4.13.3 Vaksindo Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Vaksindo Avian Influenza Vaccines Product Portfolio
- 4.13.5 Vaksindo Recent Developments
- 4.14 ChengDu Tecbond
- 4.14.1 ChengDu Tecbond Company Information
- 4.14.2 ChengDu Tecbond Business Overview
- 4.14.3 ChengDu Tecbond Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 ChengDu Tecbond Avian Influenza Vaccines Product Portfolio
- 4.14.5 ChengDu Tecbond Recent Developments
- 4.15 Sindh Poultry Vaccine Centre
- 4.15.1 Sindh Poultry Vaccine Centre Company Information
- 4.15.2 Sindh Poultry Vaccine Centre Business Overview
- 4.15.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Portfolio
- 4.15.5 Sindh Poultry Vaccine Centre Recent Developments
- 4.16 Merck Animal Health
- 4.16.1 Merck Animal Health Company Information
- 4.16.2 Merck Animal Health Business Overview
- 4.16.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Merck Animal Health Avian Influenza Vaccines Product Portfolio
- 4.16.5 Merck Animal Health Recent Developments
- 4.17 Medion
- 4.17.1 Medion Company Information
- 4.17.2 Medion Business Overview
- 4.17.3 Medion Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Medion Avian Influenza Vaccines Product Portfolio
- 4.17.5 Medion Recent Developments
- 4.18 Avimex Animal Health
- 4.18.1 Avimex Animal Health Company Information
- 4.18.2 Avimex Animal Health Business Overview
- 4.18.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Avimex Animal Health Avian Influenza Vaccines Product Portfolio
- 4.18.5 Avimex Animal Health Recent Developments
- 4.19 JOVAC
- 4.19.1 JOVAC Company Information
- 4.19.2 JOVAC Business Overview
- 4.19.3 JOVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 JOVAC Avian Influenza Vaccines Product Portfolio
- 4.19.5 JOVAC Recent Developments
- 4.20 Bio-Labs
- 4.20.1 Bio-Labs Company Information
- 4.20.2 Bio-Labs Business Overview
- 4.20.3 Bio-Labs Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Bio-Labs Avian Influenza Vaccines Product Portfolio
- 4.20.5 Bio-Labs Recent Developments
5 Global Avian Influenza Vaccines Market Scenario by Region
- 5.1 Global Avian Influenza Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Avian Influenza Vaccines Sales by Region: 2021-2032
- 5.2.1 Global Avian Influenza Vaccines Sales by Region: 2021-2026
- 5.2.2 Global Avian Influenza Vaccines Sales by Region: 2027-2032
- 5.3 Global Avian Influenza Vaccines Revenue by Region: 2021-2032
- 5.3.1 Global Avian Influenza Vaccines Revenue by Region: 2021-2026
- 5.3.2 Global Avian Influenza Vaccines Revenue by Region: 2027-2032
- 5.4 North America Avian Influenza Vaccines Market Facts & Figures by Country
- 5.4.1 North America Avian Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Avian Influenza Vaccines Sales by Country (2021-2032)
- 5.4.3 North America Avian Influenza Vaccines Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Avian Influenza Vaccines Market Facts & Figures by Country
- 5.5.1 Europe Avian Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Avian Influenza Vaccines Sales by Country (2021-2032)
- 5.5.3 Europe Avian Influenza Vaccines Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Avian Influenza Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific Avian Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Avian Influenza Vaccines Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Avian Influenza Vaccines Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Avian Influenza Vaccines Market Facts & Figures by Country
- 5.7.1 South America Avian Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Avian Influenza Vaccines Sales by Country (2021-2032)
- 5.7.3 South America Avian Influenza Vaccines Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Avian Influenza Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Avian Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Avian Influenza Vaccines Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Avian Influenza Vaccines Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Avian Influenza Vaccines Sales by Type (2021-2032)
- 6.1.1 Global Avian Influenza Vaccines Sales by Type (2021-2032) & (M Doses)
- 6.1.2 Global Avian Influenza Vaccines Sales Market Share by Type (2021-2032)
- 6.2 Global Avian Influenza Vaccines Revenue by Type (2021-2032)
- 6.2.1 Global Avian Influenza Vaccines Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Avian Influenza Vaccines Revenue Market Share by Type (2021-2032)
- 6.3 Global Avian Influenza Vaccines Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Avian Influenza Vaccines Sales by Application (2021-2032)
- 7.1.1 Global Avian Influenza Vaccines Sales by Application (2021-2032) & (M Doses)
- 7.1.2 Global Avian Influenza Vaccines Sales Market Share by Application (2021-2032)
- 7.2 Global Avian Influenza Vaccines Revenue by Application (2021-2032)
- 7.2.1 Global Avian Influenza Vaccines Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Avian Influenza Vaccines Revenue Market Share by Application (2021-2032)
- 7.3 Global Avian Influenza Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Avian Influenza Vaccines Value Chain Analysis
- 8.1.1 Avian Influenza Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Avian Influenza Vaccines Production Mode & Process
- 8.2 Avian Influenza Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Avian Influenza Vaccines Distributors
- 8.2.3 Avian Influenza Vaccines Customers
9 Global Avian Influenza Vaccines Analyzing Market Dynamics
- 9.1 Avian Influenza Vaccines Industry Trends
- 9.2 Avian Influenza Vaccines Industry Drivers
- 9.3 Avian Influenza Vaccines Industry Opportunities and Challenges
- 9.4 Avian Influenza Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst